Prescription Drugs Archives - Word on Benefits

Multiemployer Plan and Public Employer Coverage of GLP-1 Drugs

Cara McMullin

26 Jun 202426 Jun 2024

New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Is Almost Ten Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer and plan sponsor coverage surrounding glucagon-like peptide-1 […]

Disease Management Employee Benefits Health Care Insurance Prescription Drugs U.S.

Employer Coverage of GLP-1 Drugs on the Rise

Cara McMullin

13 Jun 202413 Jun 2024

New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Has Increased to Almost Nine Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage surrounding glucagon-like peptide-1 (GLP-1) […]

Employee Benefits Health Care Prescription Drugs Wellness

Employer’s Role in the Obesity Epidemic

Amanda Wilke

14 May 202421 May 2024

The latest theme to hit employer-provided benefits is GLP-1 drug coverage and the costs to treat obesity while reducing other health risks. To properly respond to the obesity epidemic, employers must understand obesity, weight bias and stigma, and the effect obesity has […]

Employee Benefits Health Care Prescription Drugs

Prescription Drug Plans: Spread Pricing Explainer

Jenny Gartman, CEBS

07 Mar 202407 Mar 2024

Lawmakers, employers, consumer groups and other stakeholders have called for more transparency from pharmacy benefit managers (PBMs). Lack of transparency enables PBMs to engage in the practice of spread pricing where PBMs charge health plans more than they pay pharmacies for the […]

Canada Employee Benefits Health Care Human Resources (HR) Prescription Drugs

GLP-1 Drug Coverage in Canada

Cara McMullin

12 Feb 202421 Feb 2024

A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used […]

Diversity and Inclusion Employee Benefits Flexible Work Options LGBTQ+ Mental Health Prescription Drugs

Six Benefit Trends Making Our List for 2023

Anne Patterson

20 Dec 202320 Dec 2023

It’s THAT time of year, and the Talking Benefits pod squad is keeping up with our annual tradition of reviewing the top benefit trends of the year. We identified six big benefits trends that shaped our industry in 2023, and they are […]

AI Benefits Magazine Employee Benefits Health Care Prescription Drugs

Magazine Extra: Employee Benefits Join the Genomic Revolution Toward Precision Medicine

Guest Contributor

21 Nov 202329 Jan 2024

Employers and plan sponsors that want to offer genomic testing access and education to employees and their dependents have options to do so through workplace benefits. What kinds of tests are available, and what are the pros and cons?

Communication Employee Benefits Health Care Prescription Drugs U.S. Wellness

Employers Grapple with Claims Costs versus Outcomes of GLP-1 Drugs

Anne Patterson

14 Nov 202314 Nov 2023

A new survey report from the International Foundation of Employee Benefit Plans reveals U.S. employer coverage and considerations surrounding glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes. These drugs were also found to cause weight loss and have […]

Canada Employee Benefits Prescription Drugs Wellness

Benefit Trends Making Headlines: What to Know Now

Alyssa Hodder

01 Nov 202301 Nov 2023

Weight loss drugs have remained the headlines for most of 2023 due to their impact on diseases like obesity and diabetes. We asked Barbara A. Martinez, National Practice Leader, Drug Solutions at Canada Life to share her insights on benefit trends, GLP-1 […]

Employee Benefits Health Care Insurance Prescription Drugs

PBM Reform Momentum Heats Up

Amanda Wilke

08 Jun 202308 Jun 2023

The fight to lower prescription drug costs is underway. Congress has introduced a handful of bipartisan bills aiming to tackle drug prices by increasing transparency on pharmacy benefit managers (PBMs) and their practices that increase drug prices for group health plans. Congressional […]